The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium.

Injectable delivery matrices hold promise in enhancing engraftment and the overall efficacy of cardiac cell therapies; however, the mechanisms responsible remain largely unknown. Here we studied the interaction of a collagen matrix with circulating angiogenic cells (CACs) in a mouse myocardial infarction model. CACs + matrix treatment enhanced CAC engraftment, and improved myocardial perfusion, viability and function compared to cells or matrix alone. Integrin-linked kinase (ILK) was up-regulated in matrix-cultured CACs. Integrin α2β1 blocking prevented ILK up-regulation, significantly reduced the adhesion, proliferation, and paracrine properties of matrix-cultured CACs, and negated the benefits of CACs + matrix therapy in vivo. Furthermore, integrin α5 was essential for the angiogenic potential of CACs on matrix. These findings indicate that the synergistic therapeutic effect of CACs + matrix therapy in MI requires the matrix to enhance CAC function via α2β1 and α5 integrin signaling mechanisms, rather than simply delivering the cells.

[1]  Richard T. Lee,et al.  Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. , 2011, Cell stem cell.

[2]  A. Pozzi,et al.  TNFα Accelerates Monocyte to Endothelial Transdifferentiation in Tumors by the Induction of Integrin α5 Expression and Adhesion to Fibronectin , 2011, Molecular Cancer Research.

[3]  Seock-Won Youn,et al.  Integrin-Linked Kinase, a Hypoxia-Responsive Molecule, Controls Postnatal Vasculogenesis by Recruitment of Endothelial Progenitor Cells to Ischemic Tissue , 2006, Circulation.

[4]  C. Chung,et al.  Aggretin, a snake venom-derived endothelial integrin alpha 2 beta 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. , 2004, Blood.

[5]  A. Carpentier,et al.  Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Clinical Trial): One Year Follow-Up , 2007, Cell transplantation.

[6]  B. Geiger,et al.  Environmental sensing through focal adhesions , 2009, Nature Reviews Molecular Cell Biology.

[7]  E. Ruoslahti,et al.  Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor , 1985, Cell.

[8]  J. Tijssen,et al.  Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials , 2012, Heart.

[9]  Alain Carpentier,et al.  Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. , 2008, The Annals of thoracic surgery.

[10]  StefanieDimmeler,et al.  Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use , 2012 .

[11]  C. Chung,et al.  Aggretin, a snake venom–derived endothelial integrin α2β1 agonist, induces angiogenesis via expression of vascular endothelial growth factor , 2004 .

[12]  A. Pozzi,et al.  TNFα ACCELERATES TUMOR VASCULAR LEUKOCYTE FORMATION THROUGH THE INDUCTION OF INTEGRIN α5 EXPRESSION AND ADHESION TO FIBRONECTIN , 2011 .

[13]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[14]  P. Schirmacher,et al.  Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end‐stage dilated, ischaemic and valvular cardiomyopathy , 2006, Histopathology.

[15]  JinHur,et al.  Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells , 2005 .

[16]  D. Phinney,et al.  Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. , 2003, Cytotherapy.

[17]  Matthias P. Lutolf,et al.  Designing materials to direct stem-cell fate , 2009, Nature.

[18]  B. Wilson,et al.  Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. , 2009, The Journal of thoracic and cardiovascular surgery.

[19]  Hua-Lin Wu,et al.  Intramyocardial Peptide Nanofiber Injection Improves Postinfarction Ventricular Remodeling and Efficacy of Bone Marrow Cell Therapy in Pigs , 2010, Circulation.

[20]  Hyun-Jai Cho,et al.  Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou , 2022 .

[21]  JinHur,et al.  Integrin-Linked Kinase, a Hypoxia-Responsive Molecule, Controls Postnatal Vasculogenesis by Recruitment of Endothelial Progenitor Cells to Ischemic Tissue , 2006 .

[22]  A. Musarò,et al.  Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. , 2012, Biomaterials.

[23]  Francisco Caiado,et al.  Endothelial progenitor cells and integrins: adhesive needs , 2012, Fibrogenesis & tissue repair.

[24]  Ran Klein,et al.  Quantification of myocardial blood flow and flow reserve: Technical aspects , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[25]  E. Friedrich,et al.  Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease. , 2008, Biochemical and biophysical research communications.

[26]  B. Strauer,et al.  10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.

[27]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[28]  Richard T. Lee,et al.  Biomaterials to enhance stem cell function in the heart. , 2011, Circulation research.

[29]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[30]  Y. Yoon,et al.  Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.

[31]  David A. Cheresh,et al.  Get a ligand, get a life: integrins, signaling and cell survival , 2002, Journal of Cell Science.

[32]  A. Parenti,et al.  Human mature endothelial cells modulate peripheral blood mononuclear cell differentiation toward an endothelial phenotype. , 2008, Experimental cell research.

[33]  K. Christman,et al.  Biomaterials for the treatment of myocardial infarction: a 5-year update. , 2011, Journal of the American College of Cardiology.

[34]  V. Jeevanantham,et al.  Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis , 2012, Circulation.

[35]  T. Okano,et al.  Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model. , 2011, The Journal of thoracic and cardiovascular surgery.

[36]  Joel Price,et al.  Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood , 2006, Circulation.

[37]  Yan Zhang,et al.  Collagen-Based Matrices Improve the Delivery of Transplanted Circulating Progenitor Cells: Development and Demonstration by Ex Vivo Radionuclide Cell Labeling and In Vivo Tracking With Positron-Emission Tomography , 2008, Circulation. Cardiovascular imaging.

[38]  F. Sellke,et al.  The future of regenerating the myocardium , 2010, Current opinion in cardiology.

[39]  T. Carvalho,et al.  The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing. , 2011, Biomaterials.

[40]  D. Kuraitis,et al.  Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. , 2011, Journal of molecular and cellular cardiology.

[41]  M. Zutter,et al.  Collagen receptor integrins: rising to the challenge. , 2008, Current drug targets.

[42]  D. Kuraitis,et al.  Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation , 2013, Expert opinion on biological therapy.

[43]  J. Qin,et al.  ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. , 2012, Current opinion in cell biology.

[44]  I. Georgakoudi,et al.  Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro. , 2014, Acta biomaterialia.

[45]  Seock-Won Youn,et al.  Regulation of Endothelial Cell and Endothelial Progenitor Cell Survival and Vasculogenesis by Integrin-Linked Kinase , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[46]  Semi Kim,et al.  Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity. , 2009, Blood.

[47]  E. Marbán,et al.  Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart , 2013, EMBO molecular medicine.

[48]  J. R. Fitzpatrick,et al.  Stromal Cell-Derived Factor-1&agr; Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis , 2010, Circulation.